Effect of trefoil factors on the viscoelastic properties of mucus gels

Background Trefoil peptides (TFFs) are expressed and secreted in a tissue‐specific manner in the gastrointestinal tract. Evidence of coexpression of trefoil peptides and mucins has been demonstrated in most mucus‐producing cells in the gastrointestinal tract. The expression of trefoil peptides is up‐regulated in gastric ulceration and colitis. It is believed that TFF peptides interact with mucin to increase viscosity but this has never been confirmed. The aims of the present study were to elucidate the direct effect of trefoil peptides on mucus gel formation.

[1]  L. Thim,et al.  Human pS2/trefoil factor 1: production and characterization in Pichia pastoris. , 2001, Protein expression and purification.

[2]  R. Poulsom,et al.  Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa , 2000, Gut.

[3]  A. Corfield,et al.  Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease , 2000, Gut.

[4]  J. Newton,et al.  The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach , 2000, Gut.

[5]  C. Tomasetto,et al.  pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. , 2000, Gastroenterology.

[6]  S. Poulsen,et al.  Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat , 1999, Gut.

[7]  L. Thim,et al.  Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis , 1999, Gut.

[8]  C. Tomasetto,et al.  The pS2/TFF1 trefoil factor, from basic research to clinical applications. , 1998, Biochimica et biophysica acta.

[9]  L. Thim,et al.  Oral human spasmolytic polypeptide protects against aspirininduced gastric injury in rats , 1998, Journal of gastroenterology and hepatology.

[10]  L. Thim.  Trefoil peptides: from structure to function , 1997, Cellular and Molecular Life Sciences CMLS.

[11]  M. Fishman,et al.  Impaired Defense of Intestinal Mucosa in Mice Lacking Intestinal Trefoil Factor , 1996, Science.

[12]  P. Chambon,et al.  Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil Protein , 1996, Science.

[13]  L. Thim,et al.  Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. , 1996, Gastroenterology.

[14]  B. Sands,et al.  The trefoil peptide family. , 1996, Annual review of physiology.

[15]  L. Thim,et al.  Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. , 1995, Gastroenterology.

[16]  L. Thim,et al.  Characterization of human and rat intestinal trefoil factor produced in yeast. , 1995, Biochemistry.

[17]  R. Playford,et al.  Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. , 1995, Gastroenterology.

[18]  R. Hunt,et al.  Critical reappraisal of mucosal repair mechanisms. , 1995, Scandinavian journal of gastroenterology. Supplement.

[19]  G. Stamp,et al.  Natural Gastrointestinal Ulcer Healing Mechanism? , 1994, Journal of the Royal Society of Medicine.

[20]  Z. Dauter,et al.  Pancreatic spasmolytic polypeptide: first three-dimensional structure of a member of the mammalian trefoil family of peptides. , 1993, Structure.

[21]  R. Poulsom,et al.  Trefoil peptides: a newly recognized family of epithelial mucin-associated molecules. , 1993, The American journal of physiology.

[22]  B. Sands,et al.  Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. , 1993, The Journal of biological chemistry.

[23]  L. Thim,et al.  Purification and characterization of the trefoil peptide human spasmolytic polypeptide (hSP) produced in yeast , 1993, FEBS letters.

[24]  G. Stamp,et al.  Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. , 1993, Gastroenterology.

[25]  D. Podolsky,et al.  Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Lathe,et al.  Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. , 1991, Gastroenterology.

[27]  P. Chambon,et al.  Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues , 1990, The Journal of pathology.

[28]  R. Lathe,et al.  hSP, the domain‐duplicated homolog of pS2 protein, is co‐expressed with pS2 in stomach but not in breast carcinoma. , 1990, The EMBO journal.

[29]  L. Thim.  A new family of growth factor‐like peptides ‘Trefoil’ disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins) , 1989, FEBS letters.

[30]  D. Piotrowski,et al.  [Introduction to rheology]. , 1982, Acta haematologica Polonica.